HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antiperspirant Use Leads To Excessive Aluminum Exposure, Study Suggests

This article was originally published in The Rose Sheet

Executive Summary

Norweigan study finds use of antiperspirants after shaving or waxing could result in aluminum exposure that exceeds established “tolerable” thresholds for weekly systemic exposure to the substance by 900-fold. Study conducted by Norway’s Scientific Committee for Food Safety considered both antiperspirants and lipstick/lip gloss as well as food in assessment of aluminum exposure.

You may also be interested in...



Skin-Absorption Data Needed On Aluminum In Cosmetics – SCCS

Further skin-absorption studies are needed to measure internal exposure to aluminum before a safe concentration limit can be determined for cosmetic products containing the metal, the European Commission’s Scientific Committee on Consumer Safety says in an opinion published April 11. However, available evidence on products formulated with aluminum does not link exposure to an increased risk of breast cancer or neurodegenerative diseases, the SCCS says.

Aluminum-Containing Antiperspirant Renal Warning Mandated By FDA

Antiperspirants containing aluminum will be required to carry a renal dysfunction warning due to risks associated with possible increased absorption of the ingredient, according to the OTC Antiperspirant Drug Products Final Monograph

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel